Evolus (EOLS) EPS (Weighted Average and Diluted) (2020 - 2026)
Evolus (EOLS) reported EPS (Weighted Average and Diluted) of -$0.16 for Q1 2026, up 46.67% on a YoY basis from -$0.11 in Q1 2025, and down 8034.64% quarter-over-quarter from $0.0 in Q4 2025.
Evolus (EOLS) EPS (Weighted Average and Diluted) (2020 - 2026) Analysis & Trends
Evolus has reported EPS (Weighted Average and Diluted) for 7 years, with the latest figure at -$0.16 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 46.67% year-over-year to -$0.16; the trailing twelve-month figure through Mar 2026 stood at -$0.67 (up 23.86% YoY), and the FY2025 full-year result was -$0.8, up 1.23% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.16, down from $0.0 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $0.0 in Q4 2025, with the low at -$0.42 in Q2 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.25 across 5 years, with a median of -$0.26 in 2023.
- Annual changes were most pronounced in 2022 — EPS (Weighted Average and Diluted) sank 293.75% — and 2025, when it jumped 102.02%.
- Evolus' EPS (Weighted Average and Diluted) stood at -$0.24 in 2022, then grew by 16.67% to -$0.2 in 2023, then surged by 50.0% to -$0.1 in 2024, then jumped by 102.02% to $0.0 in 2025, then sank by 8034.64% to -$0.16 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.16 (Q1 2026), $0.0 (Q4 2025), and -$0.24 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.80 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn | -0.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.16 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | -0.24 |
| Jun 30, 2025 | -0.27 |
| Mar 31, 2025 | -0.30 |
| Dec 31, 2024 | -0.10 |
| Sep 30, 2024 | -0.30 |
| Jun 30, 2024 | -0.18 |
| Mar 31, 2024 | -0.22 |
| Dec 31, 2023 | -0.20 |
| Sep 30, 2023 | -0.30 |
| Jun 30, 2023 | -0.32 |
| Mar 31, 2023 | -0.26 |
| Dec 31, 2022 | -0.24 |
| Sep 30, 2022 | -0.36 |
| Jun 30, 2022 | -0.42 |
| Mar 31, 2022 | -0.31 |
| Dec 31, 2021 | -0.34 |
| Sep 30, 2021 | -0.35 |
| Jun 30, 2021 | -0.31 |